Mumbai, January 2 (Udaipur Kiran): Shares of Trident Lifeline Ltd moved higher on Thursday after the company announced that it has increased its stake in its subsidiary, Trident Mediquip Limited. The stock was trading at ₹322.00, up by ₹3.00 or 0.94 per cent on the BSE.
The scrip opened at ₹327.00 and touched an intraday high of ₹327.00 and a low of ₹317.00. A total of 17,400 shares were traded during the session. The stock’s 52-week high stands at ₹327.00, recorded on January 2, 2025, while its 52-week low is ₹222.00, touched on March 4, 2025. The company’s current market capitalisation is ₹384.24 crore.
Promoters hold a 63.11 per cent stake in the company, while institutional and non-institutional investors hold 8.12 per cent and 28.78 per cent respectively.
Trident Lifeline has acquired an additional 9.04 per cent equity stake in its subsidiary, Trident Mediquip Limited (TML), from existing shareholders. Following this transaction, the company’s total shareholding in TML has increased from 51 per cent to 60.04 per cent. The acquisition involved an investment of approximately ₹4.42 crore.
The move strengthens Trident Lifeline’s controlling interest in its subsidiary and aligns with its long-term strategy to expand operations in the healthcare and pharmaceutical segments. Trident Mediquip is engaged in the medical equipment and healthcare solutions space, supporting the parent company’s growth initiatives.
Trident Lifeline is primarily engaged in the pharmaceutical business, focusing on ethical marketing in both domestic and international markets.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
